AERI
Aerie Pharmaceuticals
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
161 hedge funds and large institutions have $1.23B invested in Aerie Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 61 funds opening new positions, 49 increasing their positions, 35 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
40% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 35
29% more call options, than puts
Call options by funds: $34.6M | Put options by funds: $26.8M
Holders
161
Holding in Top 10
8
Calls
$34.6M
Puts
$26.8M
Top Buyers
| 1 | +$30.1M | |
| 2 | +$26.3M | |
| 3 | +$21.1M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$18.9M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$16.6M |
Top Sellers
| 1 | -$44.6M | |
| 2 | -$17M | |
| 3 | -$14.2M | |
| 4 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
-$7.78M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$7.54M |